Al Otay Abdulhakim, Sarhan Osama, El-Tholoth Hossam S, Alhelaly Ahmed, Al Akrash Hamad, Al Ghanbar Mustafa, Al Bedaiwi Khaled, Nakshabandi Ziad, Obeid Ali
Division of Pediatric Urology, Department of Urology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Urology and Nephrology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Urol Ann. 2018 Jul-Sep;10(3):287-290. doi: 10.4103/UA.UA_116_17.
The aim is to assess the outcomes of different approaches for the management of renal stones associated with horseshoe kidneys (HSKs) in our institution over a 12-year period.
A retrospective review of 144 patients with HSKs who presented from 2000 to 2012 was performed. Twenty-eight patients (19.4%) were found to have renal stones. Demographic data were collected; the method of treatment and the outcomes of stone management were reviewed. We excluded patients with non-functioning moieties and associated genitourinary anomalies, and those with incomplete data.
We included 25 patients, of which 16 males (64%) and 9 females (36%), with a mean age of 37 years. Mean serum creatinine level was 66 mmol/L. Eleven patients with a stone size <8 mm were treated expectantly with medical treatment, with only one patient requiring endoscopic intervention. Six patients (24%) with a stone size between 1 cm and ≤2 cm were treated with extracorporeal shock wave lithotripsy (ESWL) with the placement of double J stents, and seven patients (28%) with a stone size of >2 cm were treated with percutaneous nephrolithotomy. One patient with a 10 mm stone was treated using flexible ureteroscopy. No significant perioperative complications were encountered.
Indications, methods of treatment, and outcomes of management of stones associated with HSKs were comparable to those for stones associated with normal kidneys. Tailored approach based on stone size is highly recommended. ESWL accompanied with ureteric stenting is a promising strategy for the management of stones associated with HSKs in selected patients requiring intervention.
本研究旨在评估我院12年间马蹄肾(HSK)合并肾结石的不同治疗方法的疗效。
对2000年至2012年期间就诊的144例马蹄肾患者进行回顾性研究。发现28例患者(19.4%)合并肾结石。收集人口统计学数据;回顾治疗方法及结石处理结果。排除肾功能不全及合并泌尿生殖系统畸形患者,以及数据不完整患者。
纳入25例患者,其中男性16例(64%),女性9例(36%),平均年龄37岁。平均血清肌酐水平为66 mmol/L。11例结石直径<8 mm的患者采用保守治疗,仅1例患者需要内镜干预。6例结石直径在1 cm至≤2 cm之间的患者采用体外冲击波碎石术(ESWL)并置入双J管,7例结石直径>2 cm的患者采用经皮肾镜取石术。1例10 mm结石患者采用软性输尿管镜治疗。未发生严重围手术期并发症。
马蹄肾合并肾结石的治疗指征、治疗方法及治疗结果与正常肾合并肾结石相似。强烈推荐根据结石大小采取个体化治疗方法。对于部分需要干预的患者,ESWL联合输尿管支架置入术是治疗马蹄肾合并肾结石的一种有前景的策略。